Non-Omics |
Clinicopathological |
Neural Networks, Decision Tree, Logistic Regression |
Breast Cancer [122] |
Non-Omics |
Clinicopathological |
ANN, SVM, semi-supervised learning |
Breast Cancer [123] |
Non-Omics |
Clinicopathological |
ELM, Neural Networks, Genetic Algorithm |
Prostate Cancer [124] |
Non-Omics |
Clinicopathological |
Two-stage fuzzy neural network |
Prostate Cancer [125] |
Non-Omics |
Clinicopathological |
Linear Regression, Support Vector Machines, Gradient Boosting Machines, Decision Tree, |
Lung Cancer [126] |
Non-Omics |
Radiomics |
DT, Adaboost, RUSBoost algorithm, Matthews correlation coefficient |
Gliomas [127] |
Non-Omics |
MR Images and Clinicopathological |
SVM, bagged SVM, KNN, Adaboost, RF, GBT |
Bladder Cancer [128] |
Single Omics |
Genomics |
SVM, log-rank test, Cox hazard regression model, genetic algorithm, |
Ovarian Cancer [129] |
Single Omics |
Genomics |
Pathway Based Deep Clustering Model, R89-restricted Boltzmann Machine, Deep Belief Network |
GBM and Ovarian Cancer [130] |
Single Omics |
Metabolomics |
SVM, Naive Bayes, RF, KNN, C4.5, PLS-DA, LASSO, |
Colonic Cancer [131] |
Single Omics |
Metabolomics |
SVM, RF, RPART, LDA, generalized boosted model |
Breast Cancer [132] |
Non-Omics and Single Omics |
Clinicopathological and Genomics |
Ensemble model SVM, ANN, KNN, ROC and calibration slope |
Breast Cancer [133] |
Non-Omics and Single Omics |
Clinicopathological and Genomics |
SVM, ROC |
Prostate Cancer [134] |
Non-Omics and Single Omics |
Histopathology images and proteomics |
RF, CNN |
Kidney Cancer [134] |
Multi-Omics |
Genomics, Transcriptomics and proteomics |
Random Forest Regressor, Wilcoxon signed ranked test, gene-specific model, Generic model, trans issue model and RF. l |
Breast and Ovarian Cancer [135] |